Acetylation suppresses breast cancer progression by sustaining CLYBL stability

Acetylation suppresses breast cancer progression by sustaining CLYBL stability

Abstract Background The incidence of breast cancer remains high and it remains the leading cause of cancer-related deaths in women. A better understanding of the molecular mechanisms of breast cancer and identifying novel biomarkers will help improve therapeutic strategies. Citrate lyase beta like (...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyue Deng, Chenglong Ma, Xingyu Chen, Ming Yi, Qianhua Cao, Ruocen Liao, Xingyu Lei, Longchang Bai, Bin Zhao, Yingnan Wang, Zhuoyang Shen, Liujing Wu, Chenfang Dong, Zhijun Dai
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Journal of Translational Medicine
Subjects:
CLYBL
Acetylation
Breast cancer (BC)
PCAF
HDAC3
Online Access:https://doi.org/10.1186/s12967-025-06200-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12967-025-06200-3

Similar Items